Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

PaperCitations, authors & open-access status

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 254 citations, 2018 year and closed oa status.

254
Citations
2018
Year
closed
OA Status

Related on ScholarIQ

Jochen Seufert
Author
Eiichi Araki
Author
Stephen C. Bain
Author
Gottfried Rudofsky
Author
Diabetes Care
Journal
Diabetes Management and Research
Topic
470M+ articles · free account